Ilsa T. Kirby
- Oncology top 10%
- Molecular Biology
- Immunology
- Infectious Diseases top 10%
- Physiology top 5%
- Co-authors
- Michael S. CohenAndreja MikočJ.G.M. RackEdward BartlettIvan AhelPetra MikolčevićDeeksha MunnurRachy Abraham
- Topics
- PARP inhibition in cancer therapy (10 papers)Integrated Circuits and Semiconductor Failure Analysis (6 papers)Toxin Mechanisms and Immunotoxins (3 papers)
- Cited by
- PhysiologyOncologyVirology
- Journals
- Proceedings of the National Academy of SciencesNucleic Acids ResearchJournal of Molecular Biology
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Ilsa T. Kirby
13 papers receiving 499 citations
Peers
Comparison fields: 5 of 49
- Oncology 311
- Molecular Biology 214
- Immunology 142
- Infectious Diseases 122
- Physiology 78
Countries citing papers authored by Ilsa T. Kirby
This map shows the geographic impact of Ilsa T. Kirby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilsa T. Kirby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilsa T. Kirby more than expected).
Fields of papers citing papers by Ilsa T. Kirby
This network shows the impact of papers produced by Ilsa T. Kirby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilsa T. Kirby. The network helps show where Ilsa T. Kirby may publish in the future.
Co-authorship network of co-authors of Ilsa T. Kirby
This figure shows the co-authorship network connecting the top 25 collaborators of Ilsa T. Kirby. A scholar is included among the top collaborators of Ilsa T. Kirby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilsa T. Kirby. Ilsa T. Kirby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 9 | |
| 3 | 7 | |
| 4 | 63 | |
| 5 | 7 | |
| 6 | 122 | |
| 7 | 97 | |
| 8 | 53 | |
| 9 | 25 | |
| 10 | 26 | |
| 11 | 3 | |
| 12 | 31 | |
| 13 | 54 |
About Ilsa T. Kirby
Ilsa T. Kirby is a scholar working on Oncology, Physiology and Virology, having authored 13 papers that have together received 504 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (10 papers), Integrated Circuits and Semiconductor Failure Analysis (6 papers) and Toxin Mechanisms and Immunotoxins (3 papers). The work is most often cited by research in Physiology (78 citations), Oncology (311 citations) and Virology (53 citations). Ilsa T. Kirby has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Michael S. Cohen, Andreja Mikoč, J.G.M. Rack, Edward Bartlett, Ivan Ahel, Petra Mikolčević, Deeksha Munnur, Rachy Abraham, Diane E. Griffin and Anke Vermehren‐Schmaedick. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.